WE ARE ENDECE
ENDECE, LLC is a privately held biopharmaceutical company at the forefront of new drug discovery and development. Our library of proprietary compounds, invented and owned by ENDECE, was designed to stop disease by up-regulating specific biological pathways to stimulate a specific biological response. We focus on diseases whose treatment options are limited or non-existent and whose causes may not be well understood including demyelinating diseases such as, neuromyelitis optica spectrum disorder (NMOSD), multiple sclerosis (MS), osmotic demyelination syndrome (ODS), and Alzheimer’s disease (cognition).
ENDECE was founded in 2006 and is located in Mequon, Wisconsin.